E&P Financial Group is an Australian Securities Exchange listed financial services business with a history spanning over 30 years. E&P’s operations can be grouped into three segments:
▪ E&P Wealth
▪ E&P Capital
▪ E&P Funds
The group voluntarily delisted in December 2024.
|
NEWS: Tagged in Goldminers consolidate deals lead | 16 Jul 2025 |
|
RANKING: 335 Down from 234 in Public Companies - non WA list | 02 Oct 2023 |
|
NEWS: Tagged in Woolworths hopes for return to normalcy | 25 Aug 2022 |
|
|
ADDED: Added to Public Companies - non WA list | 01 Apr 2022 |
|
NEW ROLE: Matt Weaver, Non-Executive Director | 03 Nov 2020 |
|
NEW ROLE: David Evans, Executive Chair | 03 Nov 2020 |
|
NEW ROLE: Anthony W Pascoe, Non-Executive Director | 03 Nov 2020 |
|
NEW ROLE: Sally Herman, Non-Executive Director | 03 Nov 2020 |
|
|
NEW ROLE: Josephine Linden, Non-Executive Director | 03 Nov 2020 |
|
NEW ROLE: Paul Ryan, Chief Financial Officer, Company Secretary | 03 Nov 2020 |
| Name | Position | Year Started |
|---|---|---|
|
|
Executive Chair
|
2017 |
|
|
Non-Executive Director
|
| Name | Position | Year Started | Year Ended |
|---|---|---|---|
|
|
Chief Financial Officer, Company Secretary
|
2020 | 2022 |
|
|
Non-Executive Director
|
2020 | 2021 |
|
|
Non-Executive Director
|
||
|
|
Non-Executive Director
|
0 |
| Date | Company | Transaction Type | Total Value | |
|---|---|---|---|---|
| PYC Therapeutics | Placement + entitlement offer | $594.83m | >> | |
| Botanix Pharmaceuticals | Placement | $40.00m | >> | |
| PYC Therapeutics | Entitlement offer | $145.81m | >> | |
| PYC Therapeutics | Entitlement offer | $74.66m | >> | |
| PYC Therapeutics | Placement | $30.00m | >> |
